<DOC>
	<DOC>NCT00573599</DOC>
	<brief_summary>ED patients with acute migraine will be randomized to either prochlorperazine and Bendaryl OR imitrex. VAS for pain will be monitored, along with side effects. Primary outcome measure is improvement in pain scales between the groups.</brief_summary>
	<brief_title>Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Prochlorperazine</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>Acute migraine headache Pregnant Hypertension Chest pain &lt; 18 Allergy to any of the meds</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Emergency</keyword>
	<keyword>imitrex</keyword>
	<keyword>prochlorperazine</keyword>
	<keyword>Acute Migraine Headache in the Emergency Department</keyword>
</DOC>